Back to Search
Start Over
Toward personalized medicine in patients with familial hypercholesterolemia.
- Source :
-
Atherosclerosis [Atherosclerosis] 2024 Oct; Vol. 397, pp. 118522. Date of Electronic Publication: 2024 Jun 18. - Publication Year :
- 2024
-
Abstract
- Competing Interests: Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
- Subjects :
- Humans
Cholesterol, LDL blood
Genetic Predisposition to Disease
Phenotype
Mutation
Receptors, LDL genetics
Receptors, LDL metabolism
Biomarkers blood
Hydroxymethylglutaryl-CoA Reductase Inhibitors therapeutic use
Anticholesteremic Agents therapeutic use
Risk Factors
Hyperlipoproteinemia Type II genetics
Hyperlipoproteinemia Type II blood
Hyperlipoproteinemia Type II therapy
Hyperlipoproteinemia Type II diagnosis
Precision Medicine
Subjects
Details
- Language :
- English
- ISSN :
- 1879-1484
- Volume :
- 397
- Database :
- MEDLINE
- Journal :
- Atherosclerosis
- Publication Type :
- Editorial & Opinion
- Accession number :
- 38944546
- Full Text :
- https://doi.org/10.1016/j.atherosclerosis.2024.118522